IL74642A - Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyl dicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient - Google Patents
Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyl dicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipientInfo
- Publication number
- IL74642A IL74642A IL74642A IL7464285A IL74642A IL 74642 A IL74642 A IL 74642A IL 74642 A IL74642 A IL 74642A IL 7464285 A IL7464285 A IL 7464285A IL 74642 A IL74642 A IL 74642A
- Authority
- IL
- Israel
- Prior art keywords
- dione
- dichloro
- methyl
- dicyclohexylmethyloxy
- 9alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8405222A FR2561919B1 (fr) | 1984-04-03 | 1984-04-03 | Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon |
Publications (2)
Publication Number | Publication Date |
---|---|
IL74642A0 IL74642A0 (en) | 1985-06-30 |
IL74642A true IL74642A (en) | 1988-09-30 |
Family
ID=9302777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL74642A IL74642A (en) | 1984-04-03 | 1985-03-19 | Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyl dicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient |
Country Status (16)
Country | Link |
---|---|
US (1) | US4614736A (xx) |
EP (1) | EP0161144B1 (xx) |
JP (1) | JPS60224615A (xx) |
AT (1) | ATE41604T1 (xx) |
AU (1) | AU571073B2 (xx) |
CA (1) | CA1226817A (xx) |
DE (1) | DE3568944D1 (xx) |
DK (1) | DK164478C (xx) |
FR (1) | FR2561919B1 (xx) |
GR (1) | GR850815B (xx) |
HU (1) | HU196122B (xx) |
IL (1) | IL74642A (xx) |
MA (1) | MA20388A1 (xx) |
OA (1) | OA07978A (xx) |
PT (1) | PT80214B (xx) |
ZA (1) | ZA851927B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8909559D0 (en) * | 1989-04-26 | 1989-06-14 | Smith Kline French Lab | Pharmaceutical compositions |
US5578576A (en) * | 1994-09-02 | 1996-11-26 | Dalhousie University | Method and composition for treating intestinal wounds or ulcers |
US20050059583A1 (en) * | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
US7151085B2 (en) | 2004-11-15 | 2006-12-19 | Allergan, Inc. | Therapeutic methods using cyclosporine components |
US7135455B2 (en) * | 2004-11-15 | 2006-11-14 | Allergan, Inc | Methods for the therapeutic use of cyclosporine components |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2462443A1 (fr) * | 1979-07-26 | 1981-02-13 | Roussel Uclaf | Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
FR2533928A1 (fr) * | 1982-10-05 | 1984-04-06 | Roussel Uclaf | Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments |
-
1984
- 1984-04-03 FR FR8405222A patent/FR2561919B1/fr not_active Expired
-
1985
- 1985-03-14 ZA ZA851927A patent/ZA851927B/xx unknown
- 1985-03-19 IL IL74642A patent/IL74642A/xx unknown
- 1985-03-26 MA MA20612A patent/MA20388A1/fr unknown
- 1985-03-28 DE DE8585400612T patent/DE3568944D1/de not_active Expired
- 1985-03-28 AT AT85400612T patent/ATE41604T1/de not_active IP Right Cessation
- 1985-03-28 EP EP85400612A patent/EP0161144B1/fr not_active Expired
- 1985-04-01 GR GR850815A patent/GR850815B/el unknown
- 1985-04-01 JP JP60066731A patent/JPS60224615A/ja active Pending
- 1985-04-01 US US06/718,175 patent/US4614736A/en not_active Expired - Fee Related
- 1985-04-01 DK DK146785A patent/DK164478C/da not_active IP Right Cessation
- 1985-04-02 HU HU851257A patent/HU196122B/hu not_active IP Right Cessation
- 1985-04-02 CA CA000478163A patent/CA1226817A/fr not_active Expired
- 1985-04-02 PT PT80214A patent/PT80214B/pt not_active IP Right Cessation
- 1985-04-03 OA OA58554A patent/OA07978A/xx unknown
- 1985-04-03 AU AU40800/85A patent/AU571073B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
ATE41604T1 (de) | 1989-04-15 |
FR2561919B1 (fr) | 1986-12-19 |
OA07978A (fr) | 1987-01-31 |
DE3568944D1 (en) | 1989-04-27 |
DK164478B (da) | 1992-07-06 |
MA20388A1 (fr) | 1985-10-01 |
EP0161144B1 (fr) | 1989-03-22 |
PT80214A (en) | 1985-05-01 |
EP0161144A1 (fr) | 1985-11-13 |
US4614736A (en) | 1986-09-30 |
DK146785A (da) | 1985-10-04 |
JPS60224615A (ja) | 1985-11-09 |
HU196122B (en) | 1988-10-28 |
DK164478C (da) | 1992-11-23 |
ZA851927B (en) | 1986-04-30 |
AU571073B2 (en) | 1988-03-31 |
PT80214B (en) | 1987-02-17 |
AU4080085A (en) | 1985-10-10 |
GR850815B (xx) | 1985-07-23 |
HUT44436A (en) | 1988-03-28 |
CA1226817A (fr) | 1987-09-15 |
FR2561919A1 (fr) | 1985-10-04 |
IL74642A0 (en) | 1985-06-30 |
DK146785D0 (da) | 1985-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU549102B2 (en) | Aromatic heterocyclic esters of steroids | |
DE3485647D1 (de) | Steroide und diese enthaltende therapeutische zusammensetzungen. | |
DE3465201D1 (en) | 1-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them | |
PH12415A (en) | 16a,17-cyclopentylidenedioxy-9a-fluoro-11,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate,anti-inflammatory composition and method of use thereof | |
AU5323396A (en) | Methods of treating inflammation and compositions therefor | |
IL74642A0 (en) | Pharmaceutical composition constituted by 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene-3,20-dione,and an inert excipient | |
IL53031A (en) | 21-hydroxy(halogen)-17alpha-acyloxy pregna-1,4,8-triene-3,20-diones,their preparation and pharmaceutical compositions containing them | |
JPS54986A (en) | Reducing method of voltage dependancy for fet output capacity | |
DK92183D0 (da) | 11beta-chlor-delta15-steroider, fremgangsmade til fremstilling heraf og farmaceutiske praeparater med indhold heraf | |
LV5274A3 (lv) | 22(R,S)-11 beta,21-dihidroksi-16 alpha,17-butilidenbisoksipregna-1,4-dien-3,20-diona iegusanas panemiens | |
JPS57175116A (en) | Pharmacological composition for circular alopecia treatment and therapy thereby | |
AR243198A1 (es) | Procedimiento para la elaboracion de compuesto 9alfa-21-dihalogeno-11beta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metilp regna-1,4-dien-3,20-diona | |
FR2388829A1 (fr) | Nouveaux esters de 6-chloro-11b,17a,21-trihydroxy-pregna-1,4,6-triene-3, 20-dione, leur procede de preparation et medicament les contenant | |
AR243199A1 (es) | Procedimiento para elaborar compuestos de 9alfa,21-dihalogeno-llbeta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metil- pregna-1,4-dien-3,20- diona | |
IE841831L (en) | Composition for the treatment of endometriosis based on lhrh¹and progestational agent |